Gatifloxacin ophthalmic Alternatives Compared
| Gatifloxacin ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
|---|
| Gatifloxacin ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ophthalmic Surgery, Conjunctivitis, Conjunctivitis - Bacterial. Gatifloxacin ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Conjunctivitis, Iritis, Keratitis, Cyclitis, Postoperative Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis. Lotemax may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Conjunctivitis, Eye Conditions, Trachoma. Sulfacetamide sodium ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||||||||||
| More about Gatifloxacin ophthalmic | More about Lotemax (loteprednol) | More about Sulfacetamide sodium ophthalmic | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Gatifloxacin ophthalmic has an average rating of 7.6 out of 10 from a total of 8 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 13% reported a negative effect. |
Lotemax has an average rating of 6.6 out of 10 from a total of 18 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 33% reported a negative effect. |
Sulfacetamide sodium ophthalmic has an average rating of 8.3 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Gatifloxacin ophthalmic side effects |
View all Lotemax side effects |
|||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Gatifloxacin ophthalmic prices |
View all Lotemax prices |
|
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Zymar, Zymaxid | Other loteprednol brands include: Alrex, Eysuvis, Inveltys, Lotemax SM | AK-Sulf, Bleph-10, Cetamide | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 42 drugs are known to interact with Lotemax:
|
A total of 1 drugs are known to interact with Sulfacetamide sodium ophthalmic:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
April 15, 2011 |
July 21, 1946 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Chloramphenicol ophthalmic
Chloramphenicol ophthalmic is used for conjunctivitis, bacterial
TobraDex
Tobradex (tobramycin, dexamethasone) is used to treat bacterial infections of the eyes. Includes ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Moxifloxacin ophthalmic
Moxifloxacin ophthalmic is used for conjunctivitis, bacterial, ophthalmic surgery
Tobramycin ophthalmic
Tobramycin ophthalmic is used for conjunctivitis, bacterial
Bacitracin ophthalmic
Bacitracin ophthalmic is used for conjunctivitis, bacterial
Ofloxacin ophthalmic
Ofloxacin ophthalmic is used for conjunctivitis, bacterial, corneal ulcer, ophthalmic surgery
Gentamicin ophthalmic
Gentamicin ophthalmic is used for conjunctivitis, bacterial
Erythromycin ophthalmic
Erythromycin ophthalmic is used for conjunctivitis, bacterial
Levofloxacin ophthalmic
Levofloxacin ophthalmic is used for conjunctivitis, bacterial, corneal ulcer, ophthalmic surgery
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.